Integrating multi-omics approaches has transformed cancer research by providing a comprehensive understanding of tumor biology through simultaneous analysis of genomic, transcriptomic, proteomic, metabolomic, and epigenomic datasets. By employing high-throughput data and advanced computational strategies, multi-omics approaches enable the identification of key driver mutations, intricate regulatory networks, and novel biomarkers for precision oncology. The tumor heterogeneity remains a significant challenge in the development of effective cancer diagnosis and treatment that can be circumvented using multi-omics approaches. This chapter explores the significance of multi-omics technologies in deciphering the complex molecular mechanisms underlying cancer initiation, progression, and therapeutic resistance. The discussion highlights recent advancements in integrative bioinformatics frameworks and machine learning algorithms that facilitate cancer subtyping, prognosis prediction, and therapy optimization. Further, the limitations of single-omics studies and the need for multilayered data integration to gain deeper insights into disease mechanisms are highlighted.